After 1922.gov.tw comes online, I will turn off the reservation component of vaxx.tw, leaving up the translations of the vaccine target groups. I am so grateful for everyone's work over the past few weeks. Through your hard work, we: Translated the site into 5 different languages. ...
Dr. Paul Offit, a member of the FDA's Vaccines and Related Biological Products Advisory Committee, said a vaccine taken by mouth may have better acceptance from those in the public who may be anxious about needles. Two Covid-19 vaccines authorized in the U.S. – from Pfizer and Moder...
“Approved COVID-19 vaccines afford less protection against infection from new SARS-CoV-2 variants compared with the original parental strain against which they were developed. A broadly cross-reactive vaccine may be the most effective way to protect against cu...
A new study published onBioRxiv.orgdemonstrates that Vaxart’s S-only COVID-19 clinical vaccine candidate, now being studied by Vaxart in Phase 2 trials, generated antibodies to the original COVID-19 virus strain and to the beta, delta, alpha and gamm...
Vaxxinity, Inc. (Nasdaq: VAXX), today announced results from studies demonstrating the ability of UB-612, its COVID-19 vaccine candidate, to elicit a broad immune response against multiple variants of concern, and specifically ...
The Department of Veterans Affairs was the first federal agency to require health care employees to get vaccinated against COVID-19, and now it's expanding who will need to be vaccinated in order to keep their jobs. Veterans Affairs Secretary Denis McDonough announced on "CBS This Morning" ...
In the news :: Vaxxas Awarded US$3.67 million (AU$5.4 million) from global charitable foundation, Wellcome, for Human Clinical Study of Typhoid Vaccination using Needle-Free Vaccine Patch
“In order to avert a direct and imminent danger to human life and public safety, we ask that the Covid-19 vaccination programmes be discontinued immediately,” the Group’s report stated.” The Working Group for Covid Vaccine Analysis is an interdisciplinary working group that has undertaken ...
./src/applications/vaos/tests/covid-19-vaccine/components/PlanAheadPage.unit.spec.js ./src/applications/vaos/tests/covid-19-vaccine/components/ReceivedDoseScreenerPage.unit.spec.js ./src/applications/vaos/tests/covid-19-vaccine/components/ReviewPage.unit.spec.js ...
Bay Area-based Vaxart, Inc. has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose.